APG Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

APG Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-373,224	Closed	-$43.2M	–	773
2023 Q3	$43.2M	Sell	373,224 -27,650	-7%	-$2.97M	0.09%	221
2023 Q2	$37.8M	Sell	400,874 -17,082	-4%	-$1.8M	0.08%	243
2023 Q1	$42M	Sell	417,956 -62,517	-13%	-$6.91M	0.09%	237
2022 Q4	$54.7M	Buy	480,473 +228,451	+91%	+$19M	0.1%	223
2022 Q3	$15.9M	Sell	252,022 -124,984	-33%	-$8.73M	0.04%	336
2022 Q2	$28.8M	Sell	377,006 -67,892	-15%	-$6.43M	0.07%	284
2022 Q1	$42.1M	Sell	444,898 -12,200	-3%	-$1.19M	0.08%	256
2021 Q4	$43.3M	Buy	457,098 +2,300	+0.5%	+$251K	0.07%	266
2021 Q3	$43M	Buy	454,798 +3,700	+0.8%	+$384K	0.08%	269
2021 Q2	$35.6M	Buy	451,098 +423,100	+1,511%	+$38.9M	0.06%	321
2021 Q1	$2.19M	Sell	27,998 -35,802	-56%	-$3.02M	﹤0.01%	696
2020 Q4	$3.81M	Buy	63,800 +30,700	+93%	+$2.28M	0.01%	678
2020 Q3	$2.19M	Buy	+33,100	New	+$2.28M	﹤0.01%	770
2020 Q2	–	Sell	-9,378	Closed	-$278K	–	1032
2020 Q1	$278K	Sell	9,378 -668,822	-99%	-$22.6M	﹤0.01%	888
2019 Q4	$21.9M	Buy	678,200 +135,589	+25%	+$4.16M	0.04%	417
2019 Q3	$13.6M	Buy	542,611 +314,711	+138%	+$8.14M	0.02%	497
2019 Q2	$4.82M	Buy	+227,900	New	+$5.78M	0.01%	635

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

APG Asset Management's HZNP Position: Q4 2023 in Review

APG Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 373,224 shares — an estimated $43.2M sold.

APG Asset Management first reported a position in HZNP in Q2 2019 and held it in 17 quarters. The position peaked at $54.7M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

APG Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
APG Asset Management sold 373,224 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $43.2M.
APG Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 17 quarters.
APG Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $54.7M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on APG Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.